Kerry Group’s Sensoril ashwagandha ingredient supports the quality of life and health of postmenopausal women, according to new clinical research. The study validates Sensoril’s ability to boost symptom management for women postmenopause, at 250 mg/day. Sensoril is a standardized, synergetic combination of the ashwagandha root and leaf. Kerry notes the clinical study builds on fourteen previous scientific studies proving the natural ingredient is a safe and effective solution to support overall health.
